West Virginia 2026 Regular Session

West Virginia House Bill HB5527

Introduced
2/13/26  
Refer
2/13/26  
Engrossed
3/4/26  
Refer
3/5/26  
Refer
3/5/26  
Report Pass
3/9/26  
Refer
3/9/26  
Report Pass
3/11/26  
Enrolled
3/14/26  

Caption

Relating to Wellness Reimbursement Programs

Companion Bills

No companion bills found.

Previously Filed As

WV SB909

Relating to Medicaid reimbursement rates for certain mental health diagnostic and therapeutic procedures

WV SB433

Relating to dental health care service plans

WV HB2527

To create a tuition reimbursement program for Corrections employees.

WV HB3092

Relating to financial assistance available for a prescription drug

WV HB3308

Relating to the termination of the authority’s certificate of need program

WV HB3339

Relating to cost sharing for diagnostic and supplemental breast examinations

WV HB2852

Relating to portable benefit plans

WV SB95

Allowing reimbursement for remote ultrasound procedures and fetal nonstress tests

WV SB726

Relating to medication-assisted treatment programs

WV SB310

Public Defender Services rule relating to payment of fees and reimbursement of expenses for court-appointed attorneys

Similar Bills

NJ A3344

"Mental Health Access Act;" increases Medicaid reimbursement rates for certain evidence-based behavioral health services.

NJ S3165

Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.

CT HB07191

An Act Concerning Medicaid Rate Increases, Planning And Sustainability.

LA HB398

Prohibits payment for meals and incidental expenses for state public officials and employees from exceeding amounts for such expenses established by the U.S. General Services Administration

RI H5628

Mandates all health insurance contracts, plans, or policies provide the same reimbursement to independent healthcare facilities as that of hospital affiliated facilities where the same healthcare service is provided.

NJ A2120

Requires NJ FamilyCare to reimburse inpatient providers for long-acting injectable antipsychotic drugs at outpatient reimbursement rate.

IN SB0140

Pharmacy benefits.

MA H1324

Relative to prescription drug pricing